Nucala 100MG/ML 1ML 1S
Ended Awarded Last action
- Contract number
- SPE2DR26FBTFM
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,591
Award facts
- Contract value 100% obligated
- $11,590.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,590.98 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Nucala 100mg/ml 1ml injectable medication. The delivery order, issued on December 3, 2025, with an ultimate completion date of December 4, 2025, was made without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR, which carries a $499.999 billion ceiling value and extends through December 31, 2036.
The PPV-G GEN V program represents a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical supply chain operations for Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group's role as a regional prime vendor contractor under this initiative enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The contractor's established performance history on numerous delivery orders issued by the Defense Logistics Agency demonstrates its capability to fulfill the specialized pharmaceutical requirements supporting DoD healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FBTFM?
SPE2DR26FBTFM was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26FBTFM worth?
The government has obligated $11,591 on SPE2DR26FBTFM.
Is contract SPE2DR26FBTFM an order under another contract?
Yes. SPE2DR26FBTFM is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBTFM competed?
The extent of competition for SPE2DR26FBTFM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award